Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab

Infection. 2021 Feb;49(1):195-196. doi: 10.1007/s15010-020-01449-w. Epub 2020 Jun 15.

Authors

Andrea Claudio Comel¹, Walter Mosaner², Damiano Bragantini³, Massimiliano Lanzafame⁴

Affiliations

¹ Division of Pulmonary Medicine, P. Pederzoli Hospital, Peschiera del Garda, VR, Italy.
² Division of Intensive Care Medicine, P. Pederzoli Hospital, Peschiera del Garda, VR, Italy.
³ Infectious Diseases Consultant, P. Pederzoli Hospital, Peschiera del Garda, VR, Italy.
⁴ Division of Infectious Diseases, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. [email protected].

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / therapeutic use*
Biomarkers
COVID-19 / diagnosis*
COVID-19 / metabolism
COVID-19 / virology
COVID-19 Drug Treatment*
Combined Modality Therapy
Humans
Male
Middle Aged
Radiography, Thoracic
Receptors, Interleukin-6 / antagonists & inhibitors
SARS-CoV-2 / drug effects*
Symptom Assessment
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Biomarkers
IL6R protein, human
Receptors, Interleukin-6
tocilizumab